Articles

Topic

All Analytics Antibody-drug conjugates Bioanalytics Biologics Biosimilars Biostatistics Cancer Cell culture Clinical trials Contamination Drug development Drug product Drug substance EMA FDA GMP Mabion Manufacturing Microbiology Proteins Regulatory Vaccines Veterinary biologics

antibodies development best practices

Antibodies Development Best Practices for CDMO Collaboration

Drug development, Manufacturing, Monoclonal antibody

UV-VIS spectrometry for protein concentration analysis

UV-VIS Spectrometry for Protein Concentration Analysis: Principles and Applications

Analytics, Biologics, Proteins

Host Cell Proteins

Qualitative analysis of Host Cell Proteins using mass spectrometry

Analytics, Drug development, Drug product, Drug substance

CDMO analytical expertise

Does Your CDMO Have An Analytical Edge?

Analytics, Biosimilars, Mabion

Innovative biologics that are expected to be approved in 2025

Innovative biologics – expected drug approvals in 2025

Antibody-drug conjugates, Biologics, Bispecific antibody, Clinical trials, EMA, FDA, Monoclonal antibody, Vaccines

Biologics CDMO

Biologics CDMO Solutions for the Future of Therapeutics

Biologics, Drug development, Manufacturing

Previous 1 2 3 4 5 Next